ALLIANCE PHARMA PLC

Director's Dealing • Jun 11, 2013

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 8128G

Alliance Pharma PLC

11 June 2013

For immediate release	11 June 2013

ALLIANCE PHARMA PLC

("Alliance" or the "Company")

Exercise of Options and Director's Dealings

Alliance Pharma plc (AIM: APH), the speciality pharmaceutical company, announces that the Company was notified on 11 June 2013 that Richard Wright, a Director of the Company, exercised options to acquire 649,376 ordinary shares of 1 pence each (Ordinary Shares) at a price of 8.5p per share and 113,000 Ordinary Shares at 7.75 pence per share, all 762,376 of which were subsequently sold on 11 June 2013 at 36.5p pence per share.  Following these transactions, Mr Wright holds 190,768 Ordinary Shares in the Company, representing approximately 0.08% of the enlarged issued share capital.

Application has been made for the 762,376 Ordinary Shares to be admitted to AIM, with trading expected to commence on 17 June 2013 ("Admission").  Upon Admission the shares will rank pari passu in all respects with the existing Ordinary Shares of the Company.

After Admission, Alliance will have 249,817,643 Ordinary Shares in issue.

For further information:

### Alliance Pharma plc	### + 44 (0) 1249 466966
John Dawson, Chief Executive
Richard Wright, Finance Director
www.alliancepharma.co.uk
### Buchanan	### + 44 (0) 20 7466 5000
Mark Court / Fiona Henson / Sophie Cowles www.buchanan.uk.com
Numis Securities Limited	+ 44 (0) 20 7260 1000
Nominated Adviser: Michael Meade / Oliver Cardigan / Freddie Barnfield
Corporate Broking: David Poutney

Notes to editors:

About Alliance

Alliance, founded in 1998, is an AIM listed speciality pharmaceutical company based in Chippenham, Wiltshire, UK. The Company has a strong track record of acquiring the rights to established niche products and owns or licenses the rights to more than 60 pharmaceutical products and continues to explore opportunities to expand the range.

Alliance joined the AIM market of the London Stock Exchange in December 2003 and trades under the symbol APH.

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSNKDDDPBKDFAD